Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tracks muscle decline in rare muscular dystrophy

NCT ID NCT06390566

First seen Jan 15, 2026 · Last updated Jun 09, 2026 · Updated 28 times

Summary

This study follows 25 adults with limb-girdle muscular dystrophy 2A (LGMD2A) to measure how their muscle strength and quality of life change over time. Researchers will test arm and leg muscle strength using manual tests and motor scales. The goal is to better understand the natural course of the disease, which may help design future treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIMB GIRDLE MUSCULAR DYSTROPHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hôpital Henri Mondor

    Créteil, Île-de-France Region, 94130, France

Conditions

The condition(s) this trial relates to.

autosomal recessive limb-girdle muscular dystrophy type 2A limb-girdle muscular dystrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.